Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy

Vaccine

Volumn 25, Issue 49, 2007, Pages 8257-8261

  Puthanakit, Thanyawee ^a   Aurpibul, Linda ^a   Yoksan, Sutee ^b   Sirisanthana, Thira ^a   Sirisanthana, Virat ^c  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Human immunodeficiency virus (HIV); Japanese encephalitis virus; Protective antibody

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; DEMOGRAPHY; DRUG SAFETY; EPIDEMIC ENCEPHALITIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVACCINATION; STATISTICAL ANALYSIS; VACCINATION;

ANTIBODIES, VIRAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; HIV INFECTIONS; HUMANS; JAPANESE ENCEPHALITIS VACCINES; MALE; NEUTRALIZATION TESTS; VACCINATION;

EID: 36049001445     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.052     Document Type: Article

References (23)

1. Tsai T.F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine 18 Suppl 2 (2000) 1-25
2. Chunsuttiwat S. Japanese encephalitis in Thailand. Southeast Asian J Trop Med Public Health 20 4 (1989) 593-597
3. Poneprasert B. Japanese encephalitis in children in northern Thailand. Southeast Asian J Trop Med Public Health 20 4 (1989) 599-603
4. Thisyakorn U., and Nimmannitya S. Japanese encephalitis in Thai children, Bangkok, Thailand. Southeast Asian J Trop Med Public Health 16 1 (1985) 93-97
5. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319 10 (1988) 608-614
6. Nimmannitya S., Hutamai S., Kalayanarooj S., and Rojanasuphot S. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines. Southeast Asian J Trop Med Public Health 26 4 (1995) 689-693
7. Obaro S.K., Pugatch D., and Luzuriaga K. Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. Lancet Infect Dis 4 8 (2004) 510-518
8. Moss W.J., Clements C.J., and Halsey N.A. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 81 1 (2003) 61-70
9. Rojanasuphot S., Shaffer N., Chotpitayasunondh T., Phumiamorn S., Mock P., Chearskul S., et al. Response to JE vaccine among HIV-infected children, Bangkok, Thailand. Southeast Asian J Trop Med Public Health 29 3 (1998) 443-450
10. Puthanakit T., Oberdorfer A., Akarathum N., Kanjanavanit S., Wannarit P., Sirisanthana T., et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis 41 1 (2005) 100-107
11. Puthanakit T., Aurpibul L., Oberdorfer P., Akarathum N., Kanjananit S., Wannarit P., et al. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Clin Infect Dis 44 4 (2007) 599-604
12. Centers for Disease Control and Prevention. 1994 Revised Classification system for human immunodeficiency virus infection in children less than 13 years of age. Morb Mortal Wkly Rep 43 RR-12 (1994) 1-10
13. Russell P.K., Nisalak A., Sukhavachana P., and Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 99 (1967) 285-290
14. Tseng H.F., Tan H.F., Chang C.K., Huang W.L., and Ho W.C. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships. Am J Infect Control 31 7 (2003) 435-440
15. Siriaksorn S., Puthanakit T., Sirisanthana T., and Sirisanthana V. Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine 24 16 (2006) 3095-3099
16. Aurpibul L., Puthanakit T., Siriaksorn S., Sirisanthana T., and Sirisanthana V. Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy. HIV Med 7 7 (2006) 467-470
17. Abzug M.J., Pelton S.I., Song L.Y., Fenton T., Levin M.J., Nachman S.A., et al. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J 25 10 (2006) 920-929
18. Levin M.J., Gershon A.A., Weinberg A., Song L.Y., Fentin T., and Nowak B. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis 194 2 (2006) 247-255
19. Weinberg A., Gona P., Nachman S.A., Defechereux P., Yogev R., Hughes W., et al. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy. J Infect Dis 193 2 (2006) 302-311
20. Loa-Araya M., Aurpibul L., Puthanakit T., Sirisanthana T., and Sirisanthana V. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy. Vaccine 25 (2007) 5324-5329
21. Aurpibul L., Puthanakit T., Sirisanthana T., and Sirisanthana V. Response to measles, mumps, and rubella re-vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Clin Infect Dis 45 (2007) 637-642
22. Quina M.A., Thein S., Auvanich W., Okuno Y., Igarashi A., and Fukai K. Changes in dengue and Japanese encephalitis (JE) antibody after JE vaccination. Biken J 21 4 (1978) 149-159
23. Takahashi H., Pool V., Tsai T.F., and Chen R.T. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 18 26 (2000) 2963-2969